Sort
46,585 grants matching “heart failure”
Phase II Study of AAV9-GAA Gene Transfer in Pompe Disease
$403,073Barry J. Byrne · University Of Florida · U01 · FY2019 · HL
P2: Arhythmogenic Mechanisms
$403,064Jose S Jalife · University Of Michigan At Ann Arbor · P01 · FY2010 · HL
P2: Arhythmogenic Mechanisms
$403,064Jose S Jalife · University Of Michigan At Ann Arbor · P01 · FY2009 · HL
P2: Arhythmogenic Mechanisms
$403,064Jose S Jalife · University Of Michigan At Ann Arbor · P01 · FY2012 · HL
PRE-VASCULARIZED AND DEGRADABLE PATCHES FOR CORRECTION OF CONGENITAL HEART DEFECTS
$403,050Jeffrey G Jacot · University Of Colorado Denver · R01 · FY2019 · HL
Post-translational regulation of embryonic stem cells: a proteomic study.
$403,025Jennifer E Van Eyk · Johns Hopkins University · R01 · FY2010 · HL
Anchored Phosphatase and Transcription Factor Regulation in the Heart
$403,012Kimberly L Dodge-Kafka · University Of Connecticut Sch Of Med/Dnt · R01 · FY2016 · HL
Behavioral, dietary and pharmacological modalities of cardioprotection
$403,000Edward Lakatta · National Institute On Aging · ZIA · FY2015 · AG
Signaling mechanisms of cardioprotection and remodeling
$402,977Anthony Rosenzweig · Beth Israel Deaconess Medical Center · R01 · FY2007 · HL
CD28/B7 Costimulation Blockade-Resistant Graft Rejection
$402,977Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2007 · AI
Signaling mechanisms of cardioprotection and remodeling
$402,977Anthony Rosenzweig · Beth Israel Deaconess Medical Center · R01 · FY2008 · HL
Role of CHF1/Hey2 in Hypertrophy and Heart Failure
$402,965Michael T Chin · University Of Washington · R01 · FY2007 · HL
Role of CHF1/Hey2 in Hypertrophy and Heart Failure
$402,965Michael T Chin · University Of Washington · R01 · FY2008 · HL
AMP-activated protein kinase in hypertrophied hearts
$402,965Rong Tian · University Of Washington · R01 · FY2009 · HL
AMP-activated protein kinase in hypertrophied hearts
$402,965Rong Tian · University Of Washington · R01 · FY2010 · HL
Role of CHF1/Hey2 in Hypertrophy and Heart Failure
$402,965Michael T Chin · University Of Washington · R01 · FY2009 · HL
Caveolins and Heart Failure
$402,954David M Roth · Veterans Medical Research Fdn/San Diego · P01 · FY2016 · HL
Pericardial mRNA therapy for myocardial infarction
$402,911Dashuai Zhu · Columbia Univ New York Morningside · R01 · FY2025 · HL
Cell-drones: engineered stem cell nanovesicles as alternatives to exosomes
$402,911Ke Huang · Columbia Univ New York Morningside · R01 · FY2024 · HL
Pediatric Heart Disease Network: CHOP Membership
$402,905Children'S Hospital Of Philadelphia · U01 · FY2002 · HL
Delineating the mechanisms underlying heart valve endothelial repair
$402,885Joy Lincoln · Medical College Of Wisconsin · R01 · FY2024 · HL
Angiotensin converting enzyme, angiotensin II, and arrhythmia
$402,841Samuel C Dudley · University Of Illinois At Chicago · R01 · FY2008 · HL
Phenotypic characterization of nitric oxide regulation of cardiac function by MRI
$402,836Xin Yu · Case Western Reserve University · R01 · FY2014 · HL
Timely Response to In-Hospital Deterioration Through Design of Actionable Augmented Intelligence
$402,815Karl J. Madaras-Kelly · Idaho State University · R01 · FY2021 · GM
Myocardial Regeneration with Adult Stem Cells
$402,806Young-Sup Yoon · Steward St. Elizabeth'S Medical Center · R01 · FY2006 · HL